Evidence map›Paper›PMID 42448822›Full record

Articlenpj biomedical innovations2026

Bridging tumor biology and radiomics through an ultra-large physics-driven vascular model.

Jiayi Du, Yu Zhou, Lihua Jin, Ke Sheng

Abstract read
In one paragraph

Article in npj biomedical innovations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiayi DuDepartment of Radiation Oncology, University of California, San Francisco, CA, USA.
Yu ZhouDepartment of Mechanical & Aerospace Engineering, University of California, Los Angeles, CA, USA.
Lihua JinDepartment of Mechanical & Aerospace Engineering, University of California, Los Angeles, CA, USA. lihuajin@seas.ucla.edu.
Ke ShengDepartment of Radiation Oncology, University of California, San Francisco, CA, USA. ke.sheng@ucsf.edu.

Funding

National Science Foundation 2048219
6 · The paper itself

Abstract

Radiomics provides an appealing, non-invasive approach to probing tumor biology for potential diagnostic and prognostic applications. However, its clinical adoption is limited by challenges in interpretability, which in turn compromise its robustness. To uncover the underlying causation, we developed an ultra-large-scale (ULS) computational model that simulates heterogeneous, vascularized tumor growth under physical constraints to a scale that can be visualized in medical images. Our study revealed the pivotal role of tumor proliferation rate in driving necrosis and tissue heterogeneity and the dominant impact of oxygen consumption rate on vascularization level. Analysis of the resultant tumor Radiomics shows a causal relationship between tumor biophysical parameters and imaging features. Specifically, differences in proliferation and oxygen consumption rates result in distinct changes in radiomic image features, identifying suitable imaging modalities and quantitative imaging metrics for studying these biophysical parameters. We thus reverse-engineer the building blocks of Radiomics as a means to understand their respective biological underpinnings. This work introduces what we believe to be the first computational framework that explicitly links tumor cell biology to macroscopic imaging features-an area traditionally explored through radiomics.

Identifiers

PMID42448822
PMCPMC13369914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.